Your browser doesn't support javascript.
loading
Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.
Bramble, Matthew S; Hoff, Nicole; Gilchuk, Pavlo; Mukadi, Patrick; Lu, Kai; Doshi, Reena H; Steffen, Imke; Nicholson, Bradly P; Lipson, Allen; Vashist, Neerja; Sinai, Cyrus; Spencer, D'andre; Olinger, Garrard; Wemakoy, Emile Okitolonda; Illunga, Benoit Kebela; Pettitt, James; Logue, James; Marchand, Jonathan; Varughese, Justin; Bennett, Richard S; Jahrling, Peter; Cavet, Guy; Serafini, Tito; Ollmann Saphire, Erica; Vilain, Eric; Muyembe-Tamfum, Jean Jacques; Hensely, Lisa E; Simmons, Graham; Crowe, James E; Rimoin, Anne W.
Affiliation
  • Bramble MS; Department of Epidemiology, School of Public Health, University of California, Los Angeles.
  • Hoff N; Department of Genetic Medicine Research, Children's Research Institute, Children's National Medical Center, Washington, District of Columbia.
  • Gilchuk P; Department of Epidemiology, School of Public Health, University of California, Los Angeles.
  • Mukadi P; Vanderbilt Vaccine Center, and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Lu K; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Doshi RH; Blood Systems Research Institute, and Department of Laboratory Medicine, University of California, San Francisco.
  • Steffen I; Department of Epidemiology, School of Public Health, University of California, Los Angeles.
  • Nicholson BP; Blood Systems Research Institute, and Department of Laboratory Medicine, University of California, San Francisco.
  • Lipson A; Institute for Medical Research, Durham Veterans Affairs Medical Center, North Carolina.
  • Vashist N; Department of Epidemiology, School of Public Health, University of California, Los Angeles.
  • Sinai C; Department of Genetic Medicine Research, Children's Research Institute, Children's National Medical Center, Washington, District of Columbia.
  • Spencer D; Department of Epidemiology, School of Public Health, University of California, Los Angeles.
  • Olinger G; Department of Epidemiology, School of Public Health, University of California, Los Angeles.
  • Wemakoy EO; Boston University, School of Medicine, Department of Medicine, Massachusetts.
  • Illunga BK; Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
  • Pettitt J; Direction de la Lutte Contre les Maladies, Ministère de la Sante, Kinshasa, Democratic Republic of the Congo.
  • Logue J; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, Maryland.
  • Marchand J; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, Maryland.
  • Varughese J; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, Maryland.
  • Bennett RS; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, Maryland.
  • Jahrling P; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, Maryland.
  • Cavet G; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, Maryland.
  • Serafini T; Atreca, Inc, Redwood City.
  • Ollmann Saphire E; Atreca, Inc, Redwood City.
  • Vilain E; Skaggs Institute for Chemical Biology, La Jolla, California.
  • Muyembe-Tamfum JJ; Department of Immunology and Microbial Science, Scripps Research Institute, La Jolla, California.
  • Hensely LE; Department of Genetic Medicine Research, Children's Research Institute, Children's National Medical Center, Washington, District of Columbia.
  • Simmons G; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Crowe JE; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, Maryland.
  • Rimoin AW; Emerging Viral Pathogens Section, NIAID, NIH, Frederick, Maryland.
J Infect Dis ; 218(12): 1929-1936, 2018 11 05.
Article in En | MEDLINE | ID: mdl-30107445
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemorrhagic Fever, Ebola / Ebolavirus / Antibodies, Viral Limits: Humans Country/Region as subject: Africa Language: En Journal: J Infect Dis Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemorrhagic Fever, Ebola / Ebolavirus / Antibodies, Viral Limits: Humans Country/Region as subject: Africa Language: En Journal: J Infect Dis Year: 2018 Document type: Article